Western Wealth Management »

Fibrobiologics shares owned by Western Wealth Management

Quarter-by-quarter ownership of Fibrobiologics shares owned by Western Wealth Management from 13F filings

Historical chart of Western Wealth Management investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Western Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Western Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $264 200 1.32

More positions owned by Western Wealth Management

Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Spdr Series Trust State Street Spd (SPYG)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)

View all positions for Western Wealth Management

Top funds holding Fibrobiologics

Vanguard Capital Management
Fund Evaluation Group
Geode Capital Management
BlackRock
Cascade Financial Partners
Vanguard Fiduciary Trust
UBS Group
Goss Wealth Management
Vanguard Global Advisers
Western Wealth Management
Royal Bank of Canada
Islay Capital Management
Bnp Paribas Arbitrage, Snc
Wells Fargo & Company

View all funds holding Fibrobiologics